病毒學市場規模、佔有率和成長分析：按產品、技術、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球病毒學市場價值為 385.2 億美元，預計到 2025 年將成長至 410.7 億美元，到 2033 年將成長至 688.5 億美元，在預測期（2026-2033 年）內複合年成長率為 6.62%。

全球病毒學市場正崛起為醫療保健和生物技術領域的重要投資領域，這主要得益於新病毒威脅的不斷湧現以及以往疫情的持續影響。對平台技術的投資顯著加速了疫苗和診斷試劑的研發，實現了從基因組定序到臨床候選藥物的快速轉化。用於應對疫情的資金投入不斷增加，包括模組化mRNA和CRISPR技術，這提高了效率、降低了成本並加快了產品上市速度。此外，人工智慧驅動的診斷技術的整合正在透過改進病原體檢測和即時監測來變革整個產業，從而實現病毒株的快速識別和治療策略的最佳化。這種動態環境正在推動對專用試劑和生物製程服務的需求，為成熟企業和創新新創公司創造了強勁的商機。

全球病毒學市場按產品、技術、應用、最終用戶和地區進行細分。按產品分類，包括病毒學診斷設備、試劑盒、抗病毒藥物和疫苗。依技術分類，分為基於PCR的技術、基於定序的技術、免疫檢測技術。依應用分類，分為HIV、肝炎病毒和呼吸道病毒（包括流感和COVID-19）。依最終用戶分類，分為醫院、診斷檢查室以及製藥和生技公司。按地區分類，分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球病毒學市場成長要素

隨著人們對醫療保健的日益關注，疫苗研發領域投入巨資，促進了大學、生技公司和製藥公司之間的合作。這種合作環境加速了新型病毒抗原的發現，簡化了臨床試驗設計，並簡化了調節流程。透過共用資源和知識，企業可以更快地將有效疫苗推向市場，增強其應對新出現的病毒威脅的能力，同時拓展病毒學領域（包括產品和服務）的潛力。此外，公眾對感染疾病風險的認知不斷提高，推動了對全面病毒檢測和健全的監測計劃的需求，進一步擴大了市場。

全球病毒學市場面臨的限制因素

全球病毒學市場面臨許多限制因素，其中最主要的是病毒學產品監管要求的嚴格性。這些要求包括大量的文件資料、嚴苛的臨床證據以及合規義務。企業在適應不同地區標準的過程中，常常會遇到安全要求不一致以及額外的上市後監測責任等問題。這種複雜性增加了營運負擔，延長了研發週期，並可能導致診斷和治療藥物的上市延遲。因此，即使是最有前景的項目也可能難以吸引投資，因為資源被轉移到克服監管障礙上，而不是用於促進創新。此外，潛在政策變化帶來的不確定性也加劇了相關人員面臨的風險和顧慮。

全球病毒學市場趨勢

全球病毒學市場正呈現出向更精準診斷發展的顯著趨勢，這主要得益於次世代定序和即時檢測技術的進步。實驗室擴大採用能夠同時檢測多種病原體的多重檢測方法，從而簡化檢測流程，並提高感染疾病爆發的管理效率。臨床醫生擴大利用基因組數據來最佳化抗病毒治療，醫療系統也更加重視早期檢測，以防止病毒感染的傳播。這一趨勢推動了對攜帶式診斷設備、強大的生物資訊解決方案和協作網路的投資，從而建立了一個更行動化和數據豐富的診斷生態系統。因此，該市場正在不斷發展，以滿足高所得經濟體和新興經濟體的需求。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球病毒學市場規模：依產品類別分類

• 病毒診斷設備
• 試劑和試劑盒
• 抗病毒藥物
• 疫苗

全球病毒學市場規模：依技術分類

• 基於PCR的
• 定序鹼基
• 免疫檢測

全球病毒學市場規模：按應用領域分類

• HIV
• 肝炎
• 呼吸道病毒（流感、新冠病毒）

全球病毒學市場規模：依最終用戶分類

• 醫院
• 診斷實驗室
• 製藥和生物技術

全球病毒學市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Roche Diagnostics
• Abbott Laboratories
• Thermo Fisher Scientific
• Becton Dickinson
• bioMerieux SA
• Qiagen NV
• Hologic Inc.
• Gilead Sciences
• GlaxoSmithKline
• Merck & Co.
• Pfizer Inc.
• Johnson & Johnson
• AstraZeneca
• Moderna Inc.
• BioNTech SE
• Sanofi SA
• Bio-Rad Laboratories
• Cepheid（Danaher）
• Luminex（DiaSorin）
• Siemens Healthineers

結論與建議

Global Virology Market size was valued at USD 38.52 Billion in 2024 and is poised to grow from USD 41.07 Billion in 2025 to USD 68.85 Billion by 2033, growing at a CAGR of 6.62% during the forecast period (2026-2033).

The global virology market has emerged as a crucial sector for health and biotech investments, driven by the continuous emergence of new viral threats and the lingering impacts of past pandemics. Investment in platform technologies has significantly accelerated vaccine and diagnostic development, enabling rapid transitions from genome sequences to clinical candidates. Increased funding for pandemic preparedness, including modular mRNA and CRISPR technology, enhances efficiency and reduces costs, facilitating swift product rollouts. Additionally, the integration of AI-driven diagnostics is transforming the landscape by improving pathogen detection and real-time surveillance, which enables quicker identification of viral strains and optimized treatment strategies. This dynamic environment fosters demand for specialized reagents and bioprocessing services, resulting in robust revenue opportunities for established firms and innovative startups alike.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Virology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Virology Market Segments Analysis

The global virology market is segmented by product, technology, application, end-user, and region. Based on product, the market is segmented into virology diagnostic instruments, reagents & kits, antiviral drugs, and vaccines. Based on technology, the market is segmented into PCR-based, sequencing-based, and immunoassay technologies. Based on application, the market is segmented into HIV, hepatitis, and respiratory viruses (including influenza and COVID-19). Based on end-user, the market is segmented into hospitals, diagnostic laboratories, and pharmaceutical & biotechnology companies. Regionally, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Driver of the Global Virology Market

The increasing emphasis on preventive healthcare is driving significant investments in vaccine research and fostering collaboration among universities, biotech firms, and pharmaceutical companies. This collaborative environment accelerates the discovery of novel viral antigens, streamlines clinical trial designs, and simplifies regulatory pathways. As resources and knowledge are shared, companies can bring effective vaccines to market more quickly, enhancing their ability to manage emerging viral threats while expanding the overall potential of the virology sector, including products and services. Additionally, heightened public awareness of infectious disease risks leads to a greater demand for comprehensive virological testing and robust surveillance programs, further stimulating market expansion.

Restraints in the Global Virology Market

The Global Virology market faces significant restraints due to stringent regulatory requirements for virology products, which entail extensive documentation, rigorous clinical evidence, and compliance obligations. As companies navigate various regional standards, they often encounter discrepancies in safety requirements and additional responsibilities for post-market surveillance. This complexity increases the operational burden, resulting in prolonged development cycles that can delay the launch of diagnostics and therapeutics. Consequently, even the most promising projects may struggle to attract investment, as resources are diverted to overcoming regulatory obstacles rather than fostering innovation. Furthermore, uncertainties surrounding potential changes in policies compound the risk and hesitation experienced by stakeholders.

Market Trends of the Global Virology Market

The Global Virology market is witnessing a significant trend towards precision diagnostics, driven by advancements in next-generation sequencing and point-of-care technologies. Laboratories are increasingly adopting multiplex assays, enabling simultaneous detection of multiple pathogens, which streamlines testing processes and aids in more efficient outbreak management. Clinicians are increasingly leveraging genomic data to optimize antiviral therapies and health systems prioritize early detection to prevent virus transmission. This trend is fostering investment in portable diagnostic devices, robust bioinformatics solutions, and collaborative networks, resulting in a more agile, data-rich diagnostic ecosystem. As a consequence, the market is evolving sustainably, catering to both high-income and emerging economies.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Virology Market Size by Product & CAGR (2026-2033)

• Market Overview
• Virology Diagnostic Instruments
• Reagents & Kits
• Antiviral Drugs
• Vaccines

Global Virology Market Size by Technology & CAGR (2026-2033)

• Market Overview
• PCR-Based
• Sequencing-Based
• Immunoassay

Global Virology Market Size by Application & CAGR (2026-2033)

• Market Overview
• HIV
• Hepatitis
• Respiratory Viruses (Influenza, COVID)

Global Virology Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Labs
• Pharma & Biotech

Global Virology Market Size & CAGR (2026-2033)

• North America (Product, Technology, Application, End-User)
  • US
  • Canada
• Europe (Product, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen NV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moderna Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioNTech SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (Danaher)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex (DiaSorin)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations